BioSolix
Research-focused biotechnology company working on gene-delivery systems and anticancer therapeutics. Primary technical areas include development of nanohybrid-based transfection reagents, exosome-based delivery vehicles, peptide therapeutics that modulate cell–cell interactions, and in vitro cell viability assay reagents. The organization engages with the scientific community through conference participation.
Industries
Nr. of Employees
small (1-50)
BioSolix
Products
Transfection reagent (multiple formulations)
Research reagents formulated to enable intracellular delivery of nucleic acids across different cell types and experimental conditions.
Cell viability assay reagent (Cell Counting Kit-8, WST-8)
Colorimetric assay reagent kit for measuring cell viability, proliferation, and cytotoxicity using WST-8 chemistry.
Transfection reagent (multiple formulations)
Research reagents formulated to enable intracellular delivery of nucleic acids across different cell types and experimental conditions.
Cell viability assay reagent (Cell Counting Kit-8, WST-8)
Colorimetric assay reagent kit for measuring cell viability, proliferation, and cytotoxicity using WST-8 chemistry.
Services
Provision and distribution of transfection reagents and cell viability assay kits to research laboratories and institutions.
Provision and distribution of transfection reagents and cell viability assay kits to research laboratories and institutions.
Expertise Areas
- Gene delivery
- Transfection reagent development
- Exosome-based delivery systems
- Anticancer peptide therapeutics
Key Technologies
- Nanohybrid nanoparticles for gene delivery
- Exosome hybrid delivery vehicles
- Therapeutic peptides affecting cell adhesion
- Transfection reagent formulations
News & Updates
Booth participation at the Korean Molecular and Cell Biology Society meeting held in Jeju ICC.
Participation in a 2024 vaccine forum focused on mRNA vaccine research and development platforms hosted at K-MEDI hub.
Booth participation at the Korean Molecular and Cell Biology Society meeting held in Jeju ICC.
Booth participation at the Korean Molecular and Cell Biology Society meeting held in Jeju ICC.
Participation in a 2024 vaccine forum focused on mRNA vaccine research and development platforms hosted at K-MEDI hub.
Booth participation at the Korean Molecular and Cell Biology Society meeting held in Jeju ICC.